Medtech industry groups and other stakeholders told the US Food and Drug Administration on 2 March that one year simply isn’t enough time for device makers to transition to the agency’s proposed Quality Management System Regulation.
The QMSR was released as a draft rule on 22 February. When finalized, it will replace the FDA’s Quality System Regulation, which has been the bedrock rule for making safe...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?